DIS3 mutations in multiple myeloma impact the transcriptional signature and clinical outcome.

Todoerti K, Ronchetti D, Favasuli V, Maura F, Morabito F, Bolli N, Taiana E, Neri A

Open source

DOI
10.3324/haematol.2021.278342
Published
2022 Apr 1
Container
Haematologica
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3324/haematol.2021.278342,
  title = {DIS3 mutations in multiple myeloma impact the transcriptional signature and clinical outcome.},
  author = {Todoerti K and Ronchetti D and Favasuli V and Maura F and Morabito F and Bolli N and Taiana E and Neri A},
  year = {2022},
  journal = {Haematologica},
  doi = {10.3324/haematol.2021.278342},
  url = {https://doi.org/10.3324/haematol.2021.278342}
}

RIS

TY  - JOUR
TI  - DIS3 mutations in multiple myeloma impact the transcriptional signature and clinical outcome.
AU  - Todoerti K
AU  - Ronchetti D
AU  - Favasuli V
AU  - Maura F
AU  - Morabito F
AU  - Bolli N
AU  - Taiana E
AU  - Neri A
PY  - 2022
JO  - Haematologica
DO  - 10.3324/haematol.2021.278342
UR  - https://doi.org/10.3324/haematol.2021.278342
ER  - 

APA

K, T., D, R., V, F., F, M., F, M., N, B., E, T., & A, N. (2022). DIS3 mutations in multiple myeloma impact the transcriptional signature and clinical outcome.. Haematologica. https://doi.org/10.3324/haematol.2021.278342

Source records